Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study

CONCLUSIONS: In non-irradiated patients, cabergoline normalises IGF-1 in around one-third and achieves both IGF-1 and GH targets in approximately one out of ten cases. SRL+cabergoline is less efficient than previously reported possibly due to differences in studies methodology and impact of confounding factors.PMID:38231133 | DOI:10.1093/ejendo/lvae003
Source: European Journal of Endocrinology - Category: Endocrinology Authors: Source Type: research